Hygromycin B inhibition of protein synthesis and ribosome biogenesis in Escherichia coli

Antimicrob Agents Chemother. 2007 Feb;51(2):591-6. doi: 10.1128/AAC.01116-06. Epub 2006 Oct 16.

Abstract

The aminoglycoside antibiotic hygromycin B was examined in Escherichia coli cells for inhibitory effects on translation and ribosomal-subunit formation. Pulse-chase labeling experiments were performed, which verified lower rates of ribosomal-subunit synthesis in drug-treated cells. Hygromycin B exhibited a concentration-dependent inhibitory effect on viable-cell numbers, growth rate, protein synthesis, and 30S and 50S subunit formation. Unlike other aminoglycosides, hygromycin B was a more effective inhibitor of translation than of ribosomal-subunit formation in E. coli. Examination of total RNA from treated cells showed an increase in RNA corresponding to a precursor to the 16S rRNA, while mature 16S rRNA decreased. Northern hybridization to rRNA in cells treated with hygromycin B showed that RNase II- and RNase III-deficient strains of E. coli accumulated 16S rRNA fragments upon treatment with the drug. The results indicate that hygromycin B targets protein synthesis and 30S ribosomal-subunit assembly.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Escherichia coli / drug effects*
  • Escherichia coli / metabolism
  • Hygromycin B / pharmacology*
  • Protein Biosynthesis / drug effects*
  • Ribosomal Proteins / drug effects
  • Ribosomal Proteins / metabolism
  • Ribosomes / drug effects*

Substances

  • Anti-Bacterial Agents
  • Ribosomal Proteins
  • Hygromycin B